eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
1/2022
vol. 38
 
Share:
Share:
more
 
 
abstract:
Original article

Relationships between the pharmacological treatment method and negative symptoms, depression, social functioning and quality of life in schizophrenia patients during 11–15 years after a first psychiatric hospitalisation

Krystyna Jaracz
1
,
Krystyna Górna
2
,
Justyna Kiejda
2
,
Katarzyna Gołębiewska
2
,
Jan Jaracz
3

1.
Department of Neurological Nursing, Poznan University of Medical Sciences, Poznan, Poland;
Zakład Pielęgniarstwa Neurologicznego, Uniwersytet Medyczny w Poznaniu, Polska
2.
Department of Psychiatric Nursing, Poznan University of Medical Sciences, Poznan, Poland;
Zakład Pielęgniarstwa Psychiatrycznego, Uniwersytet Medyczny w Poznaniu
3.
Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland;
Klinika Psychiatrii Dorosłych, Uniwersytet Medyczny w Poznaniu, Polska
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 23–33
Online publish date: 2022/08/02
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
PlumX metrics:
Aim
The present study aims to analyse relationships between the way of pharmacological treatment (antipsychotic vs antipsychotic + antidepressant) and negative symptoms in a group of schizophrenia patients hospitalised for the first time 11 to 15 years ago. Depressive symptoms, social functioning, and quality of life were also scrutinised.

Methods
56 patients were assessed one month after the hospitalisation (Time 1), and then as follows: 1 year later, 4–6, 7–11 and 11–15 years after Time 1. The following measures were used: Marder’s Negative Symptoms Factor Score (NSFS), Calgary Depression Scale for Schizophrenia (CDSS), Social Functioning (SFS) and WHOQoL – Bref scales.

Results
Most patients received antipsychotic medications throughout the whole observation period (85.7–94.6%). Out of them, 69.6–77.6% were treated with antipsychotics only and 22.9–32.4% with antipsychotics + antidepressants. There were no significant relationships between the mode of treatment and the frequency of negative symptoms or significant differences between the compared groups regarding the mean scores of the CDSS, SFS, and WHOQoL at any time point of the observation.

Conclusions
The way of treatment in terms of monotherapy (antipsychotics only) vs polytherapy (+ antidepressants) did not differentiate the frequency of negative symptoms and the levels of other clinical and psychosocial indicators of the course of the disease. The findings seem to reflect lack of satisfactory fulfilment of patients’ needs concerning relieving negative symptoms of schizophrenia.

keywords:

negative symptoms, schizophrenia, pharmacotherapy

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.